Methylene Dioxymethamphetamine (MDMA) antibody

Details for Product No. ABIN969984, Supplier: Login to see New
New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Reactivity
Chemical
(30), (3)
Host
Mouse
(23), (9), (1)
Clonality
Monoclonal
Conjugate
Un-conjugated
(3), (2), (2), (2), (2), (2)
Application
Western Blotting (WB)
(22), (15), (5), (4), (4), (3), (3)
Pubmed 2 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 100 μg
Options
Shipping to United States ( )
Availability
Isotype IgG
Characteristics This is a mouse monoclonal antibody develped by using bovine thyroglobulin -MDMA conjugate. It was tested on ELISA.
Alternative Name MDMA (3,4-Methylenedioxymethamphetamine)
Target Type Chemical
Background MDMA (3,4-methylenedioxymethamphetamine) is a ring-substituted amphetamine derivatives act by increasing the net release of the monoamine neurotransmitters (serotonin, noradrenaline and, to a smaller extent, dopamine) from their respective axon terminals. It resembles the structure of the hallucinogenic material mescaline. As a result, the pharmacological effects of MDMA are a blend of those of the amphetamines and mescaline.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Add 100 µL of distilled water
Concentration 1mg/mL
Buffer Final antibody concentration is 1 mg/mL in PBS buffer.
Handling Advice Avoid repeated freeze-thaw cycles.
Storage -20 °C
Product cited in: Laux, Delalande, Mouheiche et al.: "Localization of endogenous morphine-like compounds in the mouse spinal cord." in: The Journal of comparative neurology, Vol. 520, Issue 7, pp. 1547-61, 2012 (PubMed).

Background publications Mills, Banks, Sprague et al.: "Pharmacology: uncoupling the agony from ecstasy." in: Nature, Vol. 426, Issue 6965, pp. 403-4, 2003 (PubMed).